Irritable bowel syndrome: a practical approach (Q37205398)

18 August 2017

1 reference

title

Irritable bowel syndrome: a practical approach (English)

1 reference

18 August 2017

irritable bowel syndrome

1 reference

Christian Clark

1

1 reference

PubMed ID

18595858

18 August 2017

Mark DeLegge

series ordinal

2

1 reference

18 August 2017

1 June 2008

1 reference

Nutrition in Clinical Practice

18 August 2017

1 reference

18 August 2017

23

1 reference

18 August 2017

3

1 reference

18 August 2017

263-267

1 reference

Resource utilization associated with irritable bowel syndrome in the United States 1987-1997.

18 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0884533608318107

U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608318107

Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608318107

Rectosigmoid motility response to sham feeding in irritable bowel syndrome. Evidence of a cephalic phase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608318107

Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608318107

Novel evidence for hypersensitivity of visceral sensory neural circuitry in irritable bowel syndrome patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608318107

Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608318107

Heightened visceral sensation in functional gastrointestinal disease is not site-specific. Evidence for a generalized disorder of gut sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608318107

Regional cerebral activity in normal and pathological perception of visceral pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608318107

Pathobiology of visceral pain: molecular mechanisms and therapeutic implications. III. Visceral afferent pathways: a source of new therapeutic targets for abdominal pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608318107

Clinical economics review: medical management of inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608318107

Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608318107

Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608318107

Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608318107

Postinfectious irritable bowel syndrome--a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608318107

Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608318107

Differentiated Caco-2 cells as a model for enteric invasion by Campylobacter jejuni and C. coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608318107

Impaired sympathetic nerve function in the inflamed rat intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608318107

The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608318107

Is the association between irritable bowel syndrome and abuse explained by neuroticism? A population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608318107

Hyperactivity of CRH neuronal circuits as a target for therapeutic interventions in affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608318107

Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608318107

Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608318107

Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608318107

Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608318107

Effects of tricyclic antidepressants on mechanosensitive pelvic nerve afferent fibers innervating the rat colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608318107

Amitriptyline potentiates morphine analgesia by a direct action on the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608318107

Antidepressants and chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608318107

Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608318107

Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608318107

Probiotic agents in the treatment of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608318107

Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608318107

Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533608318107

21 January 2018

Identifiers

DOI

10.1177/0884533608318107

1 reference

18 August 2017

1 reference

PubMed ID

18595858